SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

FSD Pharma Inc. – ‘F-X’ on 2/28/20 re: FSD Pharma Inc.

On:  Friday, 2/28/20, at 5:00pm ET   ·   Effective:  2/28/20   ·   Accession #:  1062993-20-1208   ·   File #:  333-236780

Previous ‘F-X’:  ‘F-X’ on 12/6/19   ·   Next & Latest:  ‘F-X’ on 4/2/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/20  FSD Pharma Inc.                   F-X         2/28/20    1:9K   FSD Pharma Inc.                   Newsfile Corp/FA

Appointment of Agent for Service of Process by a Foreign Non-Financial Entity   —   Form F-X
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-X         Appointment of Agent for Service of Process by a    HTML      9K 
                Foreign Non-Financial Entity -- formfx                           


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  FSD Pharma Inc.: Form F-X - Filed by newsfilecorp.com  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM F-X

APPOINTMENT OF AGENT FOR SERVICE
OF PROCESS AND UNDERTAKING

A. Name of issuer or person filing ("Filer"):  FSD PHARMA INC.

B. (1) This is [check one]:

[X] an original filing for the Filer.

[  ] an amended filing for the Filer.

(2) Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9) [  ]

C. Identify the filing in conjunction with which this form is being filed:

Name of registrant: FSD PHARMA INC.

Form type: Registration Statement on Form F-10

File number (if known): 333-236780

Filed by: FSD PHARMA INC.

Date filed (if filed concurrently, so indicate): February 28, 2020, concurrently herewith

D. The Filer is incorporated or organized under the laws of Ontario and has its principal place of business at:

520 William Street
Cobourg, Ontario K9A 3A5
Telephone: (416) 854-8884

E. The Filer designates and appoints CT Corporation System (the "Agent"), located at:

28 Liberty Street
New York, New York 10005
Telephone: (212) 894-8940

as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:


(a) any investigation or administrative proceeding conducted by the Securities and Exchange Commission ("Commission"); and

(b) any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any State or of the United States, or of any of its territories or possessions, or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on the date hereof, or any purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that service of an administrative subpoena shall be effected by service upon, such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.

F. Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date that the Filer has ceased reporting under the Securities Exchange Act of 1934.

The Filer further undertakes to advise the Commission promptly of any change to the Agent's name or address during the applicable period by amendment of this Form, referencing the file number of the Form F-10 in conjunction with which the amendment is being filed.

G. The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the Form F-10, the securities to which the Form F-10 relates; and the transactions in such securities.


The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Cobourg, Ontario, Country of Canada, this 28th day of February, 2020.

 

Filer: FSD PHARMA INC.

By:      /s/ Raza Bokhari                          

Name: Raza Bokhari
Title:  Chief Executive Officer and Executive Co-Chairman

 


This statement has been signed by the following person in the capacity indicated on February 28, 2020.

 

CT CORPORATION SYSTEM,
as Agent for Service of Process for FSD PHARMA INC.

By:        /s/ Olga Hinkel              

Name: Olga Hinkel
Title:  Vice President

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-X’ Filing    Date    Other Filings
Filed on / Effective on:2/28/20F-10
 List all Filings 
Top
Filing Submission 0001062993-20-001208   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 9:59:39.1am ET